These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

16 related articles for article (PubMed ID: 8551064)

  • 1. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
    Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different patterns of HLA-DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast.
    Concha A; Ruiz-Cabello F; Cabrera T; Nogales F; Collado A; Garrido F
    Eur J Immunogenet; 1995 Aug; 22(4):299-310. PubMed ID: 7495782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients With Invasive Ductal Carcinoma Have Reduced Levels of Decorin Expression in Their Breast Tissue Compared to Patients With Fibroadenoma While Plasma Decorin Remains Unchanged.
    Falakian Z; Shahani T; Rezaie R; Mazloomzadeh S; Sirati F; Jalilvand A; Jahangiri F; Bahmani P; Jadali F; Atarian S; Eghdam-Zamir R; Biglari A
    Arch Iran Med; 2018 Nov; 21(11):509-517. PubMed ID: 30551691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
    Zheng WQ; Looi LM; Cheah PL
    Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferating cell nuclear antigen (PCNA) expression in patients with breast carcinoma in comparison to patients with benign breast diseases.
    Kalogeraki A; Tzardi M; Datseris G; Kanavaros P; Karvelas C; Chalkiadakis G; Tsiftsis D; Delides G
    In Vivo; 1994; 8(6):1053-6. PubMed ID: 7772736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TPS cytosolic levels in non-malignant breast diseases.
    Alvarez A; Martinez Rodriguez PI; Nuñez MI; Alba A; Allende MT; Ruibal Morell A
    Int J Biol Markers; 1995; 10(3):183-5. PubMed ID: 8551064
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate-specific antigen expression in a case of intracystic carcinoma of the breast: characterization of immunoreactive protein and literature surveys.
    Mannello F; Sebastiani M; Amati S; Gazzanelli G
    Clin Chem; 1997 Aug; 43(8 Pt 1):1448-54. PubMed ID: 9267327
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.